[1]李锐亮 张奇峰.Marshall静脉无水乙醇消融在持续性心房颤动导管射频消融中的应用[J].心血管病学进展,2025,(9):806.[doi:10.16806/j.cnki.issn.1004-3934.2025.09.009]
　LI Ruiliang,ZHANG Qifeng.MarshallMarshall()[J].Advances in Cardiovascular Diseases,2025,(9):806.[doi:10.16806/j.cnki.issn.1004-3934.2025.09.009]
点击复制

Marshall静脉无水乙醇消融在持续性心房颤动导管射频消融中的应用()

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年9期
页码:
806
栏目:
综述
出版日期:
2025-09-25

文章信息/Info

Title:
MarshallMarshall()
作者:
李锐亮1; 2 张奇峰1; 2
(1.广东医科大学 广东 湛江 52400;2.梅州市人民医院 广东 梅州 514031)
Author(s):
LI Ruiliang1; 2;  ZHANG Qifeng1; 2
Guangdong Medical University,Zhanjiang 524000,Guangdong,China2.Meizhou Peoples Hospital, Meizhou 514031,Guangdong,China)
关键词:
持续性心房颤动; Marshall韧带; Marshall静脉; 无水乙醇消融; 导管射频消融（射频导管消融？）
Keywords:
Persistent atrial fibrillation; Ligament of Marshall; Vein of Marshall; Anhydrous ethanol ablation; Radiofrequency catheter ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2025.09.009
摘要:
导管射频消融是心房颤动治疗中节律控制的主要方法之一，但在治疗持续性心房颤动中维持远期窦性心律方面仍有待提高。Marshall韧带因其特殊的解剖位置和其与心房颤动的相关性成为当下的研究热点。近年来临床研究表明，Marshall静脉无水乙醇消融联合导管射频消融（射频导管消融？）策略在持续性心房颤动治疗中显现出良好的临床效果，提高了术后远期窦性心律维持率，同时并未增加并发症发生率。现就Marshall韧带相关心律失常发生的解剖学、生理学基础以及Marshall静脉无水乙醇消融的治疗机制、可行性、安全性、有效性以及并发症等方面进行综述。
Abstract:
Radiofrequency catheter ablation is one of the primary methods for rhythm control in the treatment of atrial fibrillation(AF),but it still needs to improve to keep long-term maintenance of sinus rhythm in therapy for patients with persistent AF. Ligament of Marshall has become a research focus due to its special anatomical location and its correlation with AF. In recent years,clinical studies have shown that Marshall’s intravenous anhydrous ethanol ablation combined with radiofrequency catheter ablation strategy has shown good clinical efficacy in the treatment of persistent AF,improving postoperative long-term sinus rhythm maintenance rates without increasing the incidence of complications. This article reviews the anatomical and physiological basis of Marshall ligament related arrhythmia,as well as the treatment mechanism,feasibility,safety,effectiveness,and complications of Marshall intravenous anhydrous ethanol ablation

参考文献/References:

[1]. 中华医学会心血管病学分会,中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志,2023,51(6):572-618.
[2]. Chen C,Zhou X,Zhu M,et al. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation:a systematic review and meta-analysis of evidence from randomized controlled trials[J]. J Interv Card Electrophysiol,2018,52(1):9-18.
[3]. Rodríguez-Ma?ero M,Schurmann P,Valderrábano M. Ligament and vein of Marshall:A therapeutic opportunity in atrial fibrillation[J]. Heart Rhythm,2016,13(2):593-601.
[4]. Valderrábano M,Peterson LE,Swarup V,et al. Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation:the VENUS randomized clinical trial[J]. JAMA,2020,324(16):1620-1628.
[5]. Sang C,Liu Q,Lai Y,et al. Pulmonary vein isolation with optimized linear ablation vs pulmonary vein isolation alone for persistent AF:the PROMPT-AF randomized clinical trial[J]. JAMA,2025,333(5):381-389.
[6]. Takigawa M,Martin C,Ja?s P. Mechanisms of vein of marshall-related tachyarrhythmias and the impact of ethanol infusion[J]. Rev Cardiovasc Med,2024,25(4):112.
[7]. Yang N,Zou Y,Wen B,et al. Development of neuromodulation for atrial fibrillation:a narrative review[J]. J Thorac Dis,2024,16(5):3472-3483.
[8]. Makino M,Inoue S,Matsuyama TA,et al. Diverse myocardial extension and autonomic innervation on ligament of Marshall in humans[J]. J Cardiovasc Electrophysiol,2006,17(6):594-599.
[9]. Chang HY,Lo LW,Lin YJ,et al. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy[J]. J Cardiovasc Electrophysiol,2013,24(3):250-258.
[10]. Liu CM,Lo LW,Lin YJ,et al. Long-term efficacy and safety of adjunctive ethanol infusion into the vein of Marshall during catheter ablation for nonparoxysmal atrial fibrillation[J]. J Cardiovasc Electrophysiol,2019,30(8):1215-1228.
[11]. Han S,Joung B,Scanavacca M,et al. Electrophysiological characteristics of the Marshall bundle in humans[J]. Heart Rhythm,2010,7(6):786-793.
[12]. Vlachos K,Denis A,Takigawa M,et al. The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation[J]. Heart Rhythm,2019,16(9):1341-1347.
[13]. Barrio-Lopez MT,Sanchez-Quintana D,Garcia-Martinez J,et al. Epicardial connections involving pulmonary veins:the prevalence,predictors, and implications for ablation outcome[J]. Circ Arrhythm Electrophysiol,2020,13(1):e007544.
[14]. Depes D,Mennander A,Immonen P,et al. The autonomic nerves around the vein of Marshall:a postmortem study with clinical implications[J]. APMIS,2024,132(6):430-443.
[15]. Báez-Escudero JL,Keida T,Dave AS,et al. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium:implications for atrial fibrillation[J]. J Am Coll Cardiol,2014,63(18):1892-1901.
[16]. Yu X,He W,Qin Z,et al. Selective ablation of the ligament of Marshall attenuates atrial electrical remodeling in a short-term rapid atrial pacing canine model[J]. J Cardiovasc Electrophysiol,2018;29(9):1299-1307.
[17]. Huang L,Gao M,Lai Y,et al. The adjunctive effect for left pulmonary vein isolation of vein of Marshall ethanol infusion in persistent atrial fibrillation[J]. Europace,2023,25(2):441-449.
[18]. Zuo S,Sang C,Long D,et al. Efficiency and durability of EIVOM on acute reconnection after mitral isthmus bidirectional block[J]. JACC Clin Electrophysiol,2024,10(4):685-694.
[19]. Nakashima T,Pambrun T,Vlachos K,et al. Impact of vein of marshall ethanol infusion on mitral isthmus block: efficacy and durability[J]. Circ Arrhythm Electrophysiol,2020,13(12):e008884.
[20]. Laredo M,Ferchaud V,Thomas O,et al. Durability of left atrial lesions after ethanol infusion in the vein of marshall[J]. JACC Clin Electrophysiol,2022,8(1):41-48.
[21]. Keida T,Fujita M,Okishige K,et al. Elimination of non-pulmonary vein ectopy by ethanol infusion in the vein of Marshall[J]. Heart Rhythm,2013,10(9):1354-1356.
[22]. Sousonis V,Combes S,Pinon P,et al. A novel stepwise approach incorporating ethanol infusion in the vein of Marshall for the ablation of persistent atrial fibrillation[J]. Front Cardiovasc Med,2023,10:1194687.
[23]. Valderrábano M,Chen HR,Sidhu J,et al. Retrograde ethanol infusion in the vein of Marshall: regional left atrial ablation, vagal denervation and feasibility in humans[J]. Circ Arrhythm Electrophysiol,2009,2(1):50-56.
[24]. Krisai P,Pambrun T,Nakatani Y,et al. How to perform ethanol ablation of the vein of Marshall for treatment of atrial fibrillation[J]. Heart Rhythm,2021,18(7):1083-1087.
[25]. Andronache M,Pastorcici A,Amet D,et al. Acute mitral isthmus block during catheter ablation with vein of Marshall ethanol infusion:Angiographic considerations[J]. Arch Cardiovasc Dis,2024,117(2):119-127.
[26]. Kamakura T,Derval N,Duchateau J,et al. Vein of marshall ethanol infusion:feasibility,pitfalls,and complications in over 700 patients[J]. Circ Arrhythm Electrophysiol,2021,14(8):e010001.
[27]. Clarnette JA,Brooks AG,Mahajan R,et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation:a systematic review and meta-analysis[J]. Europace,2018,20(FI_3):f366-f376.
[28]. Luo T,Chen Y,Xiong X,et al. Efficacy and safety of the vein of Marshall ethanol infusion with radiofrequency catheter ablation for the treatment of persistent atrial fibrillation in elderly patients[J]. Front Cardiovasc Med,2023,10:1276317.
[29]. Lai Y,Liu X,Sang C,et al. Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the "upgraded 2C3L" approach) for catheter ablation of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol,2021,32(7):1849-1856.
[30]. He Z,Yang L,Bai M,et al. Feasibility,efficacy,and safety of ethanol infusion into the vein of Marshall for atrial fibrillation:a meta-analysis[J]. Pacing Clin Electrophysiol,2021,44(7):1151-1162.
[31]. Kato K,Tanaka A,Morimoto SI,et al. Potential complications in patients undergoing an ethanol injection into the vein of Marshall[J]. J Cardiovasc Electrophysiol,2019,30(12):2743-2750.
[32]. 陈煜阳,李浩斌,郭丹颖,等. 持续性心房颤动Marshall静脉无水乙醇消融术后心包炎的特点及处理[J]. 中国心脏起搏与心电生理杂志,2024,38(4):258-263.
[33]. Leyton-Mange JS,Tandon K,Sze EY,et al. The Maine vein of Marshall ethanol experience: learning curve and safety[J]. J Interv Card Electrophysiol,2023,66(3):661-671.
[34]. Valderrábano M,Morales PF,Rodríguez-Ma?ero M,et al. The human left atrial venous circulation as a vascular route for atrial pharmacological therapies:effects of ethanol infusion[J]. JACC Clin Electrophysiol,2017,3(9):1020-1032.
[35]. Gillis K,O’Neill L,Wielandts JY,et al. Vein of Marshall ethanol infusion as first step for mitral isthmus linear ablation[J]. JACC Clin Electrophysiol,2022,8(3):367-376.
[36]. Lam A,Küffer T,Hunziker L,et al. Efficacy and safety of ethanol infusion into the vein of Marshall for mitral isthmus ablation[J]. J Cardiovasc Electrophysiol,2021,32(6):1610-1619.
[37].Ma Y,Hu M,Guo L,et al. Clinical influence of ethanol infusion in the vein of marshall on left atrial appendage occlusion:results of feasibility and safety during implantation and at 60-day follow-up[J]. J Clin Med,2023,12(5):1960.
[38].Liu S,Yu X,Luo D,et al. Ablation of the ligament of marshall and left stellate ganglion similarly reduces ventricular arrhythmias during acute myocardial infarction[J]. Circ Arrhythm Electrophysiol,2018,11(5):e005945.

相似文献/References:

[1]代丽媛 杜文娟 于波.冷冻球囊消融在持续性心房颤动治疗中的研究进展[J].心血管病学进展,2019,(7):1024.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.015]
　DAI Liyuan,DU Wenjuan,YU Bo.Cryoballoon Ablation in the Treatment of Persistent Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(9):1024.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.015]

更新日期/Last Update: 2025-12-18